Biohaven Ltd.

Healthcare · Biotechnology

13.00$ +0.8% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Biohaven Ltd. (BHVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 371 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BHVN
Line item	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	60	214	185	–	126	239	195	290	245	491	439	344	533	424	782	111	1,003	846	1,131	142	1,372	333	136	662	619	507	383	513	419	583	511	615	459	550	409	451	466	371
Current Assets	53	209	180	–	115	228	183	272	227	474	423	328	474	363	708	90	83	667	944	95	1,171	281	81	587	544	434	311	442	349	511	441	538	383	475	324	368	386	297
Cash	52	204	176	–	104	217	168	264	217	466	417	317	428	261	316	83	-83	306	501	76	169	258	51	205	125	148	112	248	183	239	84	99	98	166	185	230	273	238
Cash & Short-Term Investments	52	204	176	–	104	217	168	264	217	466	417	317	428	261	546	83	83	366	520	76	602	258	51	465	388	335	241	382	283	437	379	486	323	405	260	319	348	268
Receivables	–	–	–	–	–	–	–	–	–	–	–	–	4.3	45	80	120	157	169	253	9.9	328	8.1	11	46	48	11	15	13	8.4	7.5	5.3	2.6	–	–	–	–	–	–
Inventory	–	–	–	–	–	–	–	–	–	–	–	–	4.6	9.0	20	40	58	64	75	81	91	107	18	56	88	68	34	–	–	–	-5.3	–	–	–	–	–	–	–
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	18	15	20	20	24	52	–	50	50	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1.4	–	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.4
Intangible Assets	–	–	–	–	–	–	–	–	–	–	–	–	41	41	40	39	58	58	57	18	56	18	18	18	18	18	19	18	18	18	18	18	18	18	18	18	18	18
Total Liabilities	40	21	28	–	18	120	129	139	148	304	320	352	411	460	936	35	1,221	1,242	1,662	47	1,838	71	35	123	146	119	93	85	117	199	195	192	199	416	426	399	337	359
Current Liabilities	15	18	22	–	17	13	15	20	24	45	47	66	122	166	217	30	396	399	462	42	576	63	28	90	114	88	62	55	87	156	152	154	164	124	113	116	52	63
Short-Term Debt	4.5	4.8	–	–	–	–	–	–	–	–	–	–	–	–	–	0.7	–	–	–	63	–	1.1	1.1	3.0	–	–	3.3	3.3	3.4	3.6	3.7	3.8	4.7	4.7	5.5	5.8	5.9	4.7
Accounts Payable	4.0	6.0	8.8	–	9.1	4.0	4.7	11	8.2	14	12	14	30	17	44	2.8	65	60	49	4.8	56	3.7	4.7	11	14	12	9.5	16	36	17	20	18	19	20	17	12	10	12
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	627	–	–	–	–	–	–	–	–	–	–	–	–	–	257	268	239	242	259
Shareholders' Equity	-54	193	156	–	108	119	66	151	97	187	119	-7.4	122	-35	-212	17	77	-454	-588	35	-462	262	100	539	472	387	290	428	301	384	316	423	259	135	-17	52	130	12
Retained Earnings	-94	-133	-176	–	-288	-327	-389	-444	-506	-717	-823	-972	-1,145	-1,326	-1,521	-1,739	-2,004	-2,215	-2,387	-2,586	-2,702	-3,144	–	-91	-162	-252	-355	-499	-679	-999	-1,159	-1,346	-1,567	-1,766	-1,939	-2,085	-2,215	-2,352
Shares Outstanding	13	26	36	36	37	39	40	40	44	45	52	52	56	59	60	48	48	65	39	39	39	39	39	61	68	68	68	80	82	88	94	101	102	102	106	120	148	151

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings